Cargando…
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
BACKGROUND: Ketamine’s potent and rapid antidepressant properties have shown great promise to treat severe forms of major depressive disorder (MDD). A recently hypothesized antidepressant mechanism of action of ketamine is the inhibition of N-methyl-D-aspartate receptor–dependent bursting activity o...
Autores principales: | Rivas-Grajales, Ana Maria, Salas, Ramiro, Robinson, Meghan E, Qi, Karen, Murrough, James W, Mathew, Sanjay J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130203/ https://www.ncbi.nlm.nih.gov/pubmed/33249434 http://dx.doi.org/10.1093/ijnp/pyaa089 |
Ejemplares similares
-
Abnormal habenula functional connectivity characterizes treatment-resistant depression
por: Barreiros, Ana Rita, et al.
Publicado: (2022) -
Does the Opioid System Block or Enhance the Antidepressant Effects of
Ketamine?
por: Mathew, Sanjay J., et al.
Publicado: (2019) -
The role of the habenula in drug addiction
por: Velasquez, Kenia M., et al.
Publicado: (2014) -
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
por: O’Brien, Brittany, et al.
Publicado: (2019) -
Alterations of functional connectivity of the lateral habenula in subclinical depression and major depressive disorder
por: Yang, Lei, et al.
Publicado: (2022)